The Coming Copper Bull Run
Copper prices have nearly doubled since last year -- driven by the explosive growth in electric vehicles and soaring demand for green-powered electricity. But copper demand far outpaces supply. Multinational investment banks are predicting a 50% to 100% rise in copper prices by 2025. And this "backdoor" play may be a move to consider.
Find out how you can slip into copper

SAGE Insider Trading (Sage Therapeutics)

Insider Ownership Percentage: 4.70%
Insider Buying (Last 12 Months): $1,867,013.00
Insider Selling (Last 12 Months): $0.00

Sage Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Sage Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sage Therapeutics Share Price & Price History

Current Price: $31.69
Price Change: Price Increase of +0.05 (0.16%)
As of 05/19/2022 11:36 AM ET

This chart shows the closing price history over time for SAGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The $193 Billion US-China War You Don't Know About
They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.
The US-China "Lithium War" Is Creating Opportunity

Sage Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/5/2022George GolumbeskiDirectorBuy8,000$31.45$251,600.008,000View SEC Filing Icon  
8/5/2021Barry E. GreeneCEOBuy23,640$43.15$1,020,066.0032,440View SEC Filing Icon  
6/16/2021Barry E. GreeneCEOBuy8,800$56.32$495,616.008,800View SEC Filing Icon  
6/16/2021James M. FratesDirectorBuy1,810$55.10$99,731.001,035View SEC Filing Icon  
12/9/2019Albert RobichaudInsiderBuy25,000$64.16$1,604,000.00102,592View SEC Filing Icon  
12/9/2019Jeffrey M JonasCEOBuy7,500$64.20$481,500.0054,530View SEC Filing Icon  
8/15/2019James M. FratesDirectorSell8,000$160.58$1,284,640.00View SEC Filing Icon  
5/28/2019Jeffrey M JonasCEOSell84,661$174.83$14,801,282.6397,851View SEC Filing Icon  
5/24/2019Jeffrey M JonasCEOSell94,264$174.75$16,472,634.00116,023View SEC Filing Icon  
5/22/2019Michael CloonanInsiderSell25,000$175.00$4,375,000.00View SEC Filing Icon  
See Full Table
The Last Great Value Stock
Last year it was more profitable than Disney, Square or even Tesla.

But it's just under $2 per share.

This company's unusual business model has created a rare situation where it is both cheap and highly profitable, but it may not be $2 for long.

Check out the free presentation by clicking here.
>>>

SEC Filings (Institutional Ownership Changes) for Sage Therapeutics (NASDAQ:SAGE)

84.40% of Sage Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SAGE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Sage Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2022BNP Paribas Arbitrage SA22,285$0.74M0.0%+300.1%0.038%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd8,751$0.29M0.0%+106.9%0.015%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada19,418$0.64M0.0%-30.2%0.033%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System67,281$2.23M0.0%-7.8%0.114%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.313,457$10.38M0.0%-30.8%0.531%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC114,616$3.79M0.3%+47.5%0.194%Search for SEC Filing on Google Icon
5/16/2022Palo Alto Investors LP851,719$28.19M2.2%+9.0%1.442%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP77,866$2.58M0.0%N/A0.132%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP6,995,000$231.54M0.0%-1.8%11.843%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP675,000$22.34M1.4%-25.0%1.143%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,835,356$93.85M0.0%+30.8%4.800%Search for SEC Filing on Google Icon
5/16/2022Prelude Capital Management LLC9,997$0.33M0.0%N/A0.017%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP8,530$0.28M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.106,593$3.53M0.0%+83.2%0.180%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG132,478$4.39M0.0%-1.3%0.224%Search for SEC Filing on Google Icon
5/13/2022Bellevue Group AG3,052,404$101.03M1.2%-5.4%5.168%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp262,434$8.69M0.0%-2.9%0.444%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.267,945$8.87M0.0%+3.4%0.454%Search for SEC Filing on Google Icon
5/13/2022Easterly Investment Partners LLC33,610$1.11M0.1%N/A0.057%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP844,652$27.96M0.0%+4.1%1.430%Search for SEC Filing on Google Icon
5/13/2022Prudential Financial Inc.72,735$2.41M0.0%-46.1%0.123%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.25,364$0.84M0.0%-35.8%0.043%Search for SEC Filing on Google Icon
5/13/2022Mackenzie Financial Corp49,146$1.63M0.0%-2.2%0.083%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.4,625,003$153.09M0.0%+1.0%7.830%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP171,030$5.66M0.0%-7.4%0.290%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC311,000$10.29M2.7%-24.0%0.527%Search for SEC Filing on Google Icon
5/12/2022Great West Life Assurance Co. Can2,505$88K0.0%-16.4%0.004%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.2,754,216$91.16M0.0%-0.9%4.663%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers42,324$1.40M0.0%-11.5%0.072%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC1,027$34K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC180,979$5.99M0.0%-60.4%0.306%Search for SEC Filing on Google Icon
5/12/2022Healthcare of Ontario Pension Plan Trust Fund48,299$1.60M0.0%N/A0.082%Search for SEC Filing on Google Icon
5/12/2022Capital Fund Management S.A.56,562$1.87M0.0%-25.9%0.096%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can9,708$0.34M0.0%-65.7%0.016%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.8,634$0.29M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.42,503$1.41M0.0%-42.1%0.072%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.292,086$9.67M0.0%-9.5%0.495%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp352,623$11.67M0.0%+3.0%0.597%Search for SEC Filing on Google Icon
5/11/2022Primecap Management Co. CA68,800$2.28M0.0%+7.3%0.116%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.1,613,650$53.41M0.0%+3.3%2.732%Search for SEC Filing on Google Icon
5/11/2022WINTON GROUP Ltd13,672$0.45M0.0%+19.7%0.023%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC6,111$0.20M0.0%-26.3%0.010%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.64,400$2.13M0.0%+47.0%0.109%Search for SEC Filing on Google Icon
5/10/2022PAX Financial Group LLC11,944$0.40M0.1%N/A0.020%Search for SEC Filing on Google Icon
5/10/2022Fox Run Management L.L.C.6,435$0.21M0.1%N/A0.011%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank125,300$4.15M0.0%+7.7%0.212%Search for SEC Filing on Google Icon
5/9/2022Duality Advisers LP29,673$0.98M0.1%N/A0.050%Search for SEC Filing on Google Icon
5/9/2022Teacher Retirement System of Texas10,927$0.36M0.0%+6.8%0.018%Search for SEC Filing on Google Icon
5/9/2022Banque Cantonale Vaudoise2,069$68K0.0%-54.1%0.004%Search for SEC Filing on Google Icon
5/6/2022Los Angeles Capital Management LLC13,030$0.43M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/6/2022Sector Gamma AS118,476$3.92M0.9%+19.8%0.201%Search for SEC Filing on Google Icon
5/6/2022State Board of Administration of Florida Retirement System84,140$2.79M0.0%-1.0%0.142%Search for SEC Filing on Google Icon
5/5/2022Baillie Gifford & Co.98,766$3.27M0.0%+9.3%0.167%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund72,946$2.42M0.0%+5.7%0.123%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.31,715$1.05M0.0%-62.7%0.054%Search for SEC Filing on Google Icon
5/5/2022Pinnacle Associates Ltd.176,949$5.86M0.1%-1.1%0.300%Search for SEC Filing on Google Icon
5/4/2022SummerHaven Investment Management LLC18,130$0.60M0.3%+4.7%0.031%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.11,406$0.38M0.0%+63.6%0.019%Search for SEC Filing on Google Icon
5/4/2022Ziegler Capital Management LLC12,326$0.41M0.0%-7.9%0.021%Search for SEC Filing on Google Icon
5/4/2022Envestnet Asset Management Inc.11,512$0.38M0.0%-49.8%0.019%Search for SEC Filing on Google Icon
5/4/2022Shell Asset Management Co.11,291$0.37M0.0%-12.9%0.019%Search for SEC Filing on Google Icon
5/3/2022State of New Jersey Common Pension Fund D74,242$2.46M0.0%+8.1%0.126%Search for SEC Filing on Google Icon
5/2/2022Mutual of America Capital Management LLC22,746$0.75M0.0%-4.2%0.039%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC100,509$3.33M0.0%+594.2%0.170%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale22,220$0.76M0.0%+2.1%0.038%Search for SEC Filing on Google Icon
4/26/2022Exchange Traded Concepts LLC848$28K0.0%N/A0.001%Search for SEC Filing on Google Icon
4/26/2022Hennion & Walsh Asset Management Inc.62,552$2.07M0.1%+19.6%0.106%Search for SEC Filing on Google Icon
4/26/2022Robeco Institutional Asset Management B.V.14,511$0.48M0.0%-58.7%0.025%Search for SEC Filing on Google Icon
4/21/2022Inspire Investing LLC27,424$0.91M0.1%N/A0.046%Search for SEC Filing on Google Icon
4/21/2022Inspire Advisors LLC12,425$0.41M0.1%N/A0.021%Search for SEC Filing on Google Icon
4/21/2022Virginia Retirement Systems ET AL32,500$1.08M0.0%-9.5%0.055%Search for SEC Filing on Google Icon
3/9/2022Norges Bank478,436$20.35M0.0%N/A0.810%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC75,679$3.22M0.1%N/A0.128%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC11,000$0.47M0.1%N/A0.019%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC63,352$2.70M0.0%+25.5%0.108%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.2,779,437$118.24M0.0%-3.3%4.718%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN1,246$53K0.0%-98.3%0.002%Search for SEC Filing on Google Icon
2/16/2022The Manufacturers Life Insurance Company 335,224$14.35M0.0%-14.4%0.569%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG607,142$25.83M0.0%-3.9%1.031%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System72,998$3.11M0.0%-16.4%0.124%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC124,069$5.28M0.0%-14.9%0.211%Search for SEC Filing on Google Icon
2/16/2022Thrivent Financial for Lutherans47,139$2.01M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/15/2022Metropolitan Life Insurance Co NY1,024$44K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/15/2022Amalgamated Bank9,289$0.40M0.0%-45.5%0.016%Search for SEC Filing on Google Icon
2/15/2022Public Employees Retirement System of Ohio27,647$1.18M0.0%-3.6%0.047%Search for SEC Filing on Google Icon
2/15/2022Stifel Financial Corp45,442$1.93M0.0%-18.7%0.077%Search for SEC Filing on Google Icon
2/15/2022Legal & General Group Plc85,871$3.65M0.0%-8.4%0.146%Search for SEC Filing on Google Icon
2/15/2022Mackenzie Financial Corp50,246$2.14M0.0%+2.7%0.085%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP34,387$1.46M0.0%-56.6%0.058%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC26,750$1.14M0.0%-82.1%0.045%Search for SEC Filing on Google Icon
2/15/2022Cinctive Capital Management LP57,179$2.43M0.1%+45.1%0.097%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC101,230$4.31M0.0%-9.9%0.172%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.994,269$42.30M0.0%-20.9%1.688%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC77,683$3.31M0.3%-12.6%0.132%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC9,594$0.41M0.2%+52.8%0.016%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC73,255$3.12M0.0%N/A0.124%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd4,230$0.18M0.0%-9.6%0.007%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.336,900$14.33M0.1%-55.5%0.572%Search for SEC Filing on Google Icon
2/14/2022Guggenheim Capital LLC11,976$0.51M0.0%-77.4%0.020%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.128,055$5.45M0.0%+41.6%0.217%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Sage Therapeutics logo
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment resistant disorders, generalized anxiety disorders, and bipolar depression; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Read More on Sage Therapeutics

Today's Range

Now: $31.69
Low: $31.22
High: $32.30

50 Day Range

MA: $33.37
Low: $27.52
High: $37.99

52 Week Range

Now: $31.69
Low: $27.36
High: $79.45

Volume

1,906 shs

Average Volume

698,670 shs

Market Capitalization

$1.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Who are the company insiders with the largest holdings of Sage Therapeutics?

Sage Therapeutics' top insider investors include:
  1. Barry E Greene (CEO)
  2. Barry E Greene (CEO)
  3. George Golumbeski (Director)
  4. James M Frates (Director)
Learn More about top insider investors at Sage Therapeutics.

Who are the major institutional investors of Sage Therapeutics?

Sage Therapeutics' top institutional shareholders include:
  1. Wellington Management Group LLP — 11.84%
  2. Vanguard Group Inc. — 7.83%
  3. Bellevue Group AG — 5.17%
  4. State Street Corp — 4.80%
  5. BlackRock Inc. — 4.66%
  6. JPMorgan Chase & Co. — 2.73%
Learn More about top institutional investors of Sage Therapeutics stock.

Which major investors are selling Sage Therapeutics stock?

In the previous quarter, SAGE stock was sold by these institutional investors:
  1. Acadian Asset Management LLC
  2. Deep Track Capital LP
  3. Bellevue Group AG
  4. Goldman Sachs Group Inc.
  5. Wellington Management Group LLP
  6. Integral Health Asset Management LLC
  7. Prudential Financial Inc.
  8. Russell Investments Group Ltd.

Which major investors are buying Sage Therapeutics stock?

Within the previous quarter, SAGE stock was bought by institutional investors including:
  1. State Street Corp
  2. SG Americas Securities LLC
  3. Woodline Partners LP
  4. Group One Trading L.P.
  5. Palo Alto Investors LP
  6. JPMorgan Chase & Co.
  7. Invesco Ltd.
  8. Healthcare of Ontario Pension Plan Trust Fund
Within the last year, these company insiders have bought Sage Therapeutics stock:
  1. Barry E Greene (CEO)
  2. Barry E Greene (CEO)
  3. George Golumbeski (Director)
  4. James M Frates (Director)
Learn More investors buying Sage Therapeutics stock.
The Coming Copper Bull Run
Copper prices have nearly doubled since last year -- driven by the explosive growth in electric vehicles and soaring demand for green-powered electricity. But copper demand far outpaces supply. Multinational investment banks are predicting a 50% to 100% rise in copper prices by 2025. And this "backdoor" play may be a move to consider.
Find out how you can slip into copper